Filing Details
- Accession Number:
- 0001179110-17-010365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-13 21:22:09
- Reporting Period:
- 2017-07-11
- Filing Date:
- 2017-07-13
- Accepted Time:
- 2017-07-13 21:22:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703287 | Nabriva Therapeutics Plc | NBRV | () | E9 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1232258 | Ltd. (Cayman) Investments Healthcare Hbm | Governors Square, Suite #4-212-2 23 Lime Tree Bay Ave., West Bay Grand Cayman E9 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2017-07-11 | 3,521 | $10.52 | 2,565,661 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2017-07-12 | 13,740 | $10.50 | 2,551,921 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2017-07-13 | 39,914 | $10.54 | 2,512,007 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.59 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions ranging from $10.50 to $10.52 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
- The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price.
Billionaire Hedge Funds
